Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EP300 | Q09472 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | TERT | O14746 | 3/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.44 |
| ▸ | PPARG | P37231 | 3/20 | 0.44 |
| ▸ | PPARD | Q03181 | 3/20 | 0.44 |
| ▸ | PPARA | Q07869 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | BLM | P54132 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | FABP4 | P15090 | 2/20 | 0.44 |
| ▸ | FAAH | O00519 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | GMNN | O75496 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27984797 | 1.00 | EP300 (0.45) | EP300TSHRTERTPTPN1PPARG | |
| SCHEMBL233313 | 1.00 | EP300 (0.45) | EP300TSHRTERTPTPN1PPARG | |
| SCHEMBL27842325 | 0.85 | EP300 (0.48) | EP300TERTPTPN1PPARGPPARD | |
| SCHEMBL27842348 | 0.85 | EP300 (0.48) | EP300TERTPTPN1PPARGPPARD | |
| SCHEMBL7787797 | 0.83 | EP300 (0.45) | EP300TERTPTPN1PPARGPPARD | |
| SCHEMBL17267404 | 0.82 | KMT2A (0.53) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL17267402 | 0.82 | KMT2A (0.53) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL14663859 | 0.76 | MAPK1 (0.49) | EP300CYP1A2MAPTCYP2C19FAAH | |
| SCHEMBL4891652 | 0.76 | LMNA (0.47) | EP300TERTPTPN1PPARGPPARD | |
| SCHEMBL27768202 | 0.75 | TDP1 (0.39) | EP300TERTPTPN1PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3470084-A1 | COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS | Abraxis BioScience, LLC (US) | 2019-04-17 | — | — | EP | disclosed |
| EP-1585548-B1 | COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS | ABRAXIS BIOSCIENCE LLC (US) | 2018-06-27 | — | — | EP | disclosed |
| US-20150165047-A1 | COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS | AMERICAN BIOSCIENCE, INC. | 2015-06-18 | — | — | US | disclosed |
| US-9012518-B2 | Compositions and methods of delivery of pharmacological agents | ABRAXIS BIOSCIENCE, LLC (US) | 2015-04-21 | — | — | US | disclosed |
| US-9012519-B2 | Compositions and methods of delivery of pharmacological agents | ABRAXIS BIOSCIENCE, LLC (US) | 2015-04-21 | — | — | US | disclosed |
| US-8846771-B2 | Compositions and methods of delivery of pharmacological agents | ABRAXIS BIOSCIENCE, LLC (US) | 2014-09-30 | — | — | US | disclosed |
| US-20140039070-A1 | COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS | ABRAXIS BIOSCIENCE, LLC (US) | 2014-02-06 | — | — | US | disclosed |
| US-20140039069-A1 | COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS | ABRAXIS BIOSCIENCE, LLC (US) | 2014-02-06 | — | — | US | disclosed |
| US-20130244952-A1 | COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS | ABRAXIS BIOSCIENCE, LLC (US) | 2013-09-19 | — | — | US | disclosed |
| US-8314156-B2 | Compositions and methods of delivery of pharmacological agents | ABRAXIS BIOSCIENCE, LLC (US) | 2012-11-20 | — | — | US | disclosed |
| EP-2359859-A1 | Compositions comprising albumin nanoparticles and methods of delivery of pharmacological agents | Abraxis BioScience, LLC (US) | 2011-08-24 | — | — | EP | disclosed |
| US-7923536-B2 | Compositions and methods of delivery of pharmacological agents | ABRAXIS BIOSCIENCE, LLC (US) | 2011-04-12 | — | — | US | disclosed |
| US-7820788-B2 | injection comprising paclitaxel and albumin to reduce side effects; drugs such as propofol or paclitaxel; for cancer, arthritis, or restenosis | ABRAXIS BIOSCIENCE, LLC (US) | 2010-10-26 | — | — | US | disclosed |
| US-20100226996-A1 | injection comprising paclitaxel and albumin to reduce side effects; drugs such as propofol or paclitaxel; for cancer, arthritis, or restenosis | ABRAXIS BIOSCIENCE, INC. (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100196490-A1 | Treating breast cancer with taxol nanoparticle injection | AMERICAN BIOSCIENCE, INC. | 2010-08-05 | — | — | US | disclosed |
| US-20070129448-A1 | deferoxamine as microbiocide and albumin to reduce side effects; drugs such as propofol or paclitaxel | ABRAXIS BIOSCIENCE, INC. (US) | 2007-06-07 | — | — | US | disclosed |
| EP-1585548-A2 | COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS | American Bioscience, Inc. (US) | 2005-10-19 | — | — | EP | disclosed |
| US-20050004002-A1 | Mixture of drug with carrier such as protein; side effect reduction | AMERICAN BIOSCIENCE, INC. (US) | 2005-01-06 | — | — | US | disclosed |
| WO-2004052401-A2 | COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS | AMERICAN BIOSCIENCE, INC. (US) | 2004-06-24 | — | — | WO | disclosed |
| WO-1991007167-A1 | PROTEIN KINASE ACTIVATORS AS ENHANCERS OF MELANIN PRODUCTION | SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. (US) | 1991-05-30 | — | — | WO | disclosed |